Linked Life Data

15502601

Source:http://linkedlifedata.com/resource/pubmed/id/15502601

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15502601rdf:typepubmed:Citationlld:pubmed
pubmed-article:15502601lifeskim:mentionsumls-concept:C1170743lld:lifeskim
pubmed-article:15502601lifeskim:mentionsumls-concept:C0687676lld:lifeskim
pubmed-article:15502601lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:15502601lifeskim:mentionsumls-concept:C0728759lld:lifeskim
pubmed-article:15502601lifeskim:mentionsumls-concept:C1170283lld:lifeskim
pubmed-article:15502601lifeskim:mentionsumls-concept:C1512523lld:lifeskim
pubmed-article:15502601pubmed:issue11lld:pubmed
pubmed-article:15502601pubmed:dateCreated2004-10-25lld:pubmed
pubmed-article:15502601pubmed:abstractTextTo evaluate clinical measures of the benefit/risk ratio in a post hoc analysis of a clinical trial of d-threo-methylphenidate hydrochloride (d-MPH) and d,l-threo-methylphenidate hydrochloride (d,l-MPH).lld:pubmed
pubmed-article:15502601pubmed:languageenglld:pubmed
pubmed-article:15502601pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15502601pubmed:citationSubsetIMlld:pubmed
pubmed-article:15502601pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15502601pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15502601pubmed:statusMEDLINElld:pubmed
pubmed-article:15502601pubmed:monthNovlld:pubmed
pubmed-article:15502601pubmed:issn0890-8567lld:pubmed
pubmed-article:15502601pubmed:authorpubmed-author:WeissMargaret...lld:pubmed
pubmed-article:15502601pubmed:authorpubmed-author:PatinJohnJlld:pubmed
pubmed-article:15502601pubmed:authorpubmed-author:WasdellMichae...lld:pubmed
pubmed-article:15502601pubmed:issnTypePrintlld:pubmed
pubmed-article:15502601pubmed:volume43lld:pubmed
pubmed-article:15502601pubmed:ownerNLMlld:pubmed
pubmed-article:15502601pubmed:authorsCompleteYlld:pubmed
pubmed-article:15502601pubmed:pagination1415-21lld:pubmed
pubmed-article:15502601pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:15502601pubmed:meshHeadingpubmed-meshheading:15502601...lld:pubmed
pubmed-article:15502601pubmed:meshHeadingpubmed-meshheading:15502601...lld:pubmed
pubmed-article:15502601pubmed:meshHeadingpubmed-meshheading:15502601...lld:pubmed
pubmed-article:15502601pubmed:meshHeadingpubmed-meshheading:15502601...lld:pubmed
pubmed-article:15502601pubmed:meshHeadingpubmed-meshheading:15502601...lld:pubmed
pubmed-article:15502601pubmed:meshHeadingpubmed-meshheading:15502601...lld:pubmed
pubmed-article:15502601pubmed:meshHeadingpubmed-meshheading:15502601...lld:pubmed
pubmed-article:15502601pubmed:meshHeadingpubmed-meshheading:15502601...lld:pubmed
pubmed-article:15502601pubmed:meshHeadingpubmed-meshheading:15502601...lld:pubmed
pubmed-article:15502601pubmed:year2004lld:pubmed
pubmed-article:15502601pubmed:articleTitleA post hoc analysis of d-threo-methylphenidate hydrochloride (focalin) versus d,l-threo-methylphenidate hydrochloride (ritalin).lld:pubmed
pubmed-article:15502601pubmed:affiliationDivision of Child Psychiatry, University of British Columbia, Vancouver, Canada. mweiss@cw.bc.calld:pubmed
pubmed-article:15502601pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15502601pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15502601lld:pubmed